A Pilot Study to Determine the Effects of a Single Dose of Exenatide (Byetta) on the Acute Metabolic Responses to a Mixed Meal or Intravenous Glucose Tolerance Test in Patients With Type 1 Diabetes
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Exenatide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 05 Jul 2016 Status changed from recruiting to completed.
- 21 May 2013 New trial record